[
    {
        "molecule_name": "ORF mutation",
        "protein_target_name": "NF2",
        "binding_metric": "Viability EC50",
        "value": "0.038",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 6Association of mutation with histology in Panel 1TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueHead_NeckTP5315111179sensitive0.0001\nTABLE 6Association of mutation with histology in Panel 1TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueHead_NeckCDKN2A1249496sensitive0.0072\nTABLE 6Association of mutation with histology in Panel 1TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueHead_NeckSMAD431315175sensitive0.0262\nTABLE 6Association of mutation with histology in Panel 1TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueCervixTP531612451resistant0.0027\nTABLE 6Association of mutation with histology in Panel 1TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueLungRB12419156resistant0.0178\nTABLE 6Association of mutation with histology in Panel 1TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueBoneRB11512178sensitive0.0477\nTABLE 7Association of mutation with histology in Panel 2TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueskinCDKN2A813043resistant0.0022\nTABLE 7Association of mutation with histology in Panel 2TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueskinCDKN2A.p14632647resistant0.0004\nTABLE 7Association of mutation with histology in Panel 2TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueskinTP53275320resistant0.0036\nTABLE 7Association of mutation with histology in Panel 2TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valuesCNSCDKN2A.p14542647resistant0.0466\nTABLE 8Results of screens of cell lines with mutations in NF2.ViabilityEC50ORF mutationProtein mutationTumor TissueTumorat 2 μMPanelCo-occurringCell line(SEQ ID NO: 2)(SEQ ID NO: 3)SourcetypePanel 12Phenotypemutations647-Vc.115-1G > Cp.?urinary_tractprimary0.0380.283sensitiv"
    },
    {
        "molecule_name": "ORF mutation",
        "protein_target_name": "NF2",
        "binding_metric": "Viability EC50",
        "value": "0.283",
        "unit": null,
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 6Association of mutation with histology in Panel 1TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueHead_NeckTP5315111179sensitive0.0001\nTABLE 6Association of mutation with histology in Panel 1TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueHead_NeckCDKN2A1249496sensitive0.0072\nTABLE 6Association of mutation with histology in Panel 1TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueHead_NeckSMAD431315175sensitive0.0262\nTABLE 6Association of mutation with histology in Panel 1TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueCervixTP531612451resistant0.0027\nTABLE 6Association of mutation with histology in Panel 1TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueLungRB12419156resistant0.0178\nTABLE 6Association of mutation with histology in Panel 1TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueBoneRB11512178sensitive0.0477\nTABLE 7Association of mutation with histology in Panel 2TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueskinCDKN2A813043resistant0.0022\nTABLE 7Association of mutation with histology in Panel 2TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueskinCDKN2A.p14632647resistant0.0004\nTABLE 7Association of mutation with histology in Panel 2TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valueskinTP53275320resistant0.0036\nTABLE 7Association of mutation with histology in Panel 2TumorN mutantsN wildN mutantsN wildTissuethistype thisalltype allSourceMutationcancercancercancerscancersAssociationp-valuesCNSCDKN2A.p14542647resistant0.0466\nTABLE 8Results of screens of cell lines with mutations in NF2.ViabilityEC50ORF mutationProtein mutationTumor TissueTumorat 2 μMPanelCo-occurringCell line(SEQ ID NO: 2)(SEQ ID NO: 3)SourcetypePanel 12Phenotypemutations647-Vc.115-1G > Cp.?urinary_tractprimary0.0380.283sensitiv"
    }
]